Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$20.02 - $24.69 $70,070 - $86,415
3,500 Added 28.0%
16,000 $323,000
Q1 2024

May 15, 2024

SELL
$16.75 - $26.1 $125,625 - $195,750
-7,500 Reduced 37.5%
12,500 $311,000
Q4 2023

Feb 14, 2024

SELL
$13.29 - $22.2 $255,167 - $426,240
-19,200 Reduced 48.98%
20,000 $361,000
Q3 2023

Nov 14, 2023

BUY
$19.9 - $26.25 $282,580 - $372,750
14,200 Added 56.8%
39,200 $787,000
Q2 2023

Aug 14, 2023

SELL
$18.95 - $28.67 $534,390 - $808,494
-28,200 Reduced 53.01%
25,000 $638,000
Q1 2023

May 15, 2023

SELL
$20.02 - $31.37 $340,340 - $533,290
-17,000 Reduced 24.22%
53,200 $1.13 Million
Q4 2022

Feb 14, 2023

SELL
$20.37 - $32.9 $568,323 - $917,910
-27,900 Reduced 28.44%
70,200 $2.08 Million
Q3 2022

Nov 14, 2022

BUY
$17.49 - $28.44 $239,612 - $389,628
13,700 Added 16.23%
98,100 $2.28 Million
Q2 2022

Aug 11, 2022

BUY
$12.95 - $46.99 $620,305 - $2.25 Million
47,900 Added 131.23%
84,400 $1.42 Million
Q1 2022

May 13, 2022

SELL
$40.12 - $59.5 $690,064 - $1.02 Million
-17,200 Reduced 32.03%
36,500 $1.6 Million
Q4 2021

Feb 10, 2022

SELL
$41.7 - $61.14 $500,400 - $733,680
-12,000 Reduced 18.26%
53,700 $3.27 Million
Q3 2021

Nov 12, 2021

BUY
$27.95 - $44.24 $1.84 Million - $2.91 Million
65,700 New
65,700 $2.73 Million

Others Institutions Holding BCYC

About BICYCLE THERAPEUTICS plc


  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $436M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.